Annexon, Inc.
HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
The present disclosure is directed to humanized anti-C1q antibodies and methods of using them.
Status:
Application
Type:
Utility
Filling date:
17 May 2019
Issue date:
17 Oct 2019